Collaborative Advancement of Recovery Excellence
Translating science to service, powered by Gloo
Deni Carise, PhD, chief science officer at Recovery Centers of America, joins the BHE Podcast to discuss the shift toward value-based and recovery-oriented care, and the importance of developing standard measures of both outcomes and performance during treatment. Carise also shares data on how…
Usage of telehealth services soared in April compared to the same month in 2019, primarily driven by patients seeking treatment for mental health conditions, according to data released by FAIR Health.
The Addiction Treatment Needs Assessment is a 13-question survey developed by Shatterproof, ASAM and the proprietors of OpenBeds to determine the needs of an individual with addiction and provide guidance on appropriate treatment.
A new site is launching in July with the aim of bringing more uniformity to the measurement of addiction treatment and helping patients find care with standardized information on the quality of facilities.
Five years after the concept was developed, Conquer Addiction, an online resource that will list providers who publish their post-treatment outcomes data, is set for a June 30 launch.
Gloo and the Psychiatry & Behavioral Health Learning Network have released a whitepaper on the impact of COVID-19 based on recent survey results.
A study of national commercial insurance claims conducted found that 16.6% of patients obtained follow-up treatment after a non-fatal opioid overdose, with patients who were older, female, black or Hispanic less likely to receive follow-up care.
At the National Conference on Addiction Disorders Virtual Experience, Deni Carise, PhD, Chief Scientific Officer at Recovery Centers of America, will discuss services delivery in the time of COVID-19, the intersection of data, outcomes and innovation, and the importance of quality benchmarks and outcomes measurement.
In a study of mice, a synthetic molecule was found to reduce cocaine and methamphetamine consumption and cravings without the side effects typically associated with other interventions, according to research published Thursday in the journal Cell.
Stay-at-home and social-distancing orders have changed how PRSS programs are supporting participants during their most vulnerable moments.